Клинико-иммунологические и морфологические изменения при терапии бронхиальной астмы иммунодепрессивными препаратами
Диссертация
Объективная оценка эпидемиологической ситуации с бронхиальной астмой в России представляет определенные трудности. Несмотря на высокие показатели инвалидизации, продолжительности госпитализации и нетрудоспособности по данным Министерства здравоохранения, предоставленным для Всемирной организации здравоохранения, распространенность бронхиальной астмы в России не превышает 2−3 промилле (самые… Читать ещё >
Список литературы
- Абрамова Ж.И., Оксенгендлер Г. И. Человек и противоокисли-тельные вещества, Л-д, (1985) Наука.-226с
- Архипенко Ю.В., Каган В. Е., Козлов Ю. П. Биохимия 1983 -т.48, № 3.-С.433−440
- Банкова В.В. Роль малонового диальдегида в регуляции перекис-ного окисления липидов в норме и при патологии, Автореф. дисс. д.б.н., 1990, М.-38с.
- Болдырев А.А. Na/K-АТФаза свойства и биологическая роль. Соросовский образовательный журнал № 4, 1998, стр. 2−9.
- Борель Дж.Ф. Циклоспорин./ Руководство по иммунофармаколо-гии. Пер. с англ. под. ред. Б. С. Утешева. М.: Медицина, 1998, с.269−279
- Бронхиальная астма / под. ред. Г. Б. Федосеева. — СПб., 1996. — 463 с
- Бронхиальная астма. Под ред. акад. РАМН А. Г. Чучалина. М.: Агар, 1997, с.3−9, с.400−419.
- Варфоломеев С.Д., Гуревич К. Г. Биокинетика. Практический курс. М.: Фаир-пресс, 1999, с.720
- Видаль. Лекарственные препараты в России. М.: АстраФармСер-вис, 2005, с. 1033.
- Ю.Волков В. Т., Стрелис А. К. Бронхиальная астма (метаболическая концепция, новое в патогенезе и лечении).- Томск: Сиб. мед. ун-т, 1996.-с.9
- Галактионов. B.F. Иммунология. М.: Издательство Московского Университета, 1998, с. 123'.
- Геннис Р. Биомембраны. Молекулярная структура и функции //М., Мир.-1997.-622с
- Горбачев В.И., Введенская JI.C. Нитрооксидергическая и тиолди-сульфидная системы организма при лёгочной гипертензии у детей с врождёнными пороками сердца.//Тегга medica (лабораторная диагностика), 2004 № 1, с.22−24
- Гуревич К.Г. Вероятностное описание системы «лиганд-рецептор». Биофизика, 1999, т.44, в.6, с.1022−1026.
- Гущин И.С. Клеточно-молекулярная организация аллергического воспаления./ Бронхиальная астма. Под ред. акад. РАМН А.Г. Чу-чалина. М.: Агар, 1997, с.160−170.
- Гущин И.С. Регуляторы и стабилизаторы клеточных функций:/ Аллергическое воспаление и его фармакологический контроль. М.: Фармарус Принт, 1998, с. 197−222.
- Дубинина Е.Е., Шугай И. В. Окислительная модификация белков //Успехи совр. биол.- 1993.-t.113, № 1.- с.71−81
- Дудник Л.В., Виксна Л. М., Мацоре А. Я. Перекисное окисление липидов и его связь с изменением составо и антиокислительных свойств липидов при коматогенных формах острого вирусного гепатита В // ж. Вопр. мед.хим.- 2000.-t.46, № 6.-с.597−600
- Емельянов А.В. Причины, вызывающие воспаление. Аллергены // Механизмы воспаления бронхов и легких и противовоспалительная терапия / под ред. Г. Б. Федосеева. СПб., Нордмед-Издат. -1998.-С. 94−103
- Зыков К.А. Морфо-функциональная оценка эффективности лечения эндогенной бронхиальной астмы ингаляциями ультра-малых доз Мелфалана. Автореферат диссертации на соискание ученой степени к.м.н. М., 2000, с.13−19.
- Зыков К.А., Аверьянов А. В. Кларитромицин в лечении обострений хронической обструктивной болезни легких//. Русский медицинский журнал. Март 2008, том 16, № 2. Стр.35−39.
- Клиническая аллергология. Под ред. акад. РАМН, проф. P.M. Хаитова. М.: МЕДпресс-информ, 2002- с.234−240.
- Клиническая иммунология и аллергология. Под. ред. Г. Лолора.-мл., Т. Фишера, Д. Адельмана. М.: Практика, 2000, с.174−178.
- Клиническая иммунология. Руководство для врачей. Под: ред. акад. РАМН Е. И. Соколова. М-.: Медицина, 1998, с.27−42.
- Княжеская Н.П. Тяжелая бронхиальная астма// Consilium medi-cum, 2002, т.4, № 4, с. 189
- Колганова Н.А. Интал и его аналоги в лечении бронхиальной астмы. // Бронхиальная астма. Под ред. акад. РАМН А. Г. Чучалина. М.: Агар, 1997, т.2, с.336
- Лешукович Ю.В. Эпидемиология бронхиальной астмы./ Бронхиальная астма. Под ред. Г. Б. Федосеева. С-Петербург: Медицинское информационное агентство, 1996, с.5−12.
- Лукомский Г. И., Шулутко М. Л., Виннер М. Г. Бронхопульмоно-логия. -М.: Медицина, 1982. с. 399.
- Маслова М.Н. Физиол. 1994 .-т.80, № 7.-С.76−8030: Меерсон Ф. З: Защитные- эффекты адаптации и некоторые перспективы развития адаптационной медицины // Усп. физиол. наук .-1991.-Т.22, № 2.-с.52−89
- Методы биохимических исследований растений/ Под ред. А. И. Ермакова, В. В. Арасимовича, М.И. Смирнова-Иконникова и др. Л., 1972.
- Механизмы воспаления бронхов и легких и противовоспалительная терапия. Под ред. Г. Б. Федосеева — Санкт-Петербург: «Нордмед-Издат», 1998 с. 335−354.
- Нечаев В.И. О качественно-количественной оценке воспалительных изменений слизистой оболочки! бронхов у больных хроничет ским бронхитом.//Тер.архив: 1980: т.52: — № 3: — с.52−541
- Паттерсон Р., Греммер Л. К., Гринбергер П. А. Аллергические болезни. Диагностика и лечение. Пер. с англ. М: Геотар Медицина, 2000, с.489−491
- Подколзин А.А., Гуревич К. Г. Действие биологически активных . веществ в малых дозах. М.: КМК, 2002, с. 17, с.95−96.
- Пухальский А.Л., Межнева А. П. и др Чувствительность клеток селезенки мышей разных линий к антипролиферативному действию алкилирующих соединений.// Бюлл. Экспер. Биол., 1988, N2, с. 196−198
- Райзинг Т.Дж., Норрис Д. Б. Золото./ Руководство по иммунофар-макологии. Пер. с англ. под. ред. Б. С. Утешева. М.: Медицина, 1998, с.322−325.
- Регистр лекарственных средств России. М.: PJIC-Патент, 2005, с. 542.
- Ройт А., Бростоф Дж., Мейл Д. Иммунология. М.: Мир, 2000, с.173−174
- Сергеев П.В., Шимановский Н. Л., Петров В. И. Рецепторы. Волгоград: Семь ветров, 1999, с.637
- Соколов А.С., Скачилова С .Я., Покудин Н. И., Павлов В. М., Кис-ляк Л.В. Селективные 13−2- агонисты адренергических рецепторов./ Бронхиальная астма. Под ред. акад. РАМН А. Г. Чучалина. М.: Агар, 1997, с. 270.
- Соколов Е.И., Зыков К. А. и др. Ингаляции ультрамалых доз алкилирующих препаратов в лечении бронхиальной астмы. // Пульмонология, № 3, 2002, с.82−87.
- Соколов Е.И., Зыков К. А., Цыпленкова В. Г. и др. Сравнительная морфологическая характеристика слизистой оболочки бронхов у больных хроническим обструктивным бронхитом и бронхиальной астмой//. Архив патологии, 2000, № 4, Том 62, с.31−37
- Соколов Е.И., Пухальский А. Л., Зыков К.А.и др. Иммуномодули-рующие эффекты ингаляций ультранизких доз алкилирующегоцитостатика Мелфалана у больных бронхиальной астмой//. Пульмонология, 2002, № 5, с.84−86.
- Туев А.В., Мишланов В. Ю. Бронхиальная астма — иммунитет, гемостаз, лечение. Пермь: ИПК «Звезда», 2001, с.10−14, с.20−30.
- Турк Дж.Л. Иммуносупрессивные препараты./ Руководство по иммунофармакологии. Пер. с англ. под. ред. Б. С. Утешева. М.: Медицина, 1998, с.322−325.
- Федосеев Г. Б. Механизмы обструкции бронхов.- СПб: Мед. Информационное агенство, 1995.- 336с. с59−62, с308.49' Федосеев Г. Б., Трофимов В. И. Бронхиальная астма. СПб, 2006.
- Федосеев Г. Б., Хлопотова Г. П. Бронхиальная астма. Л.-Медицина, 1988. С. 4−12.
- Черняев А.Л., Гробова О. М. и др Морфология и цитология бронхиальной астмы.// Бронхиальная астма. Под ред А. Г. Чучалина -М.:Агар, 1997. Стр 10−51.
- Чучалин А.Г. Белая книга. Пульмонология. Россия 2003 год Москва, 2003. — 68 с.
- Чучалин А.Г. Тяжелые формы бронхиальной астмы//. Труды VII Российского Национального конгресса «Человек и лекарство». М.: 2000, с.446−449.
- Чучалин А.Г., Калманова Е. Н. Теофиллины в лечении бронхиальной астмы и, хронической обструктивной болезни легких// Consilium medicum: журнал доказательной медицины для практикующих врачей. — 2001. Том 3, N 3. С. 127−133.
- Чучалин Г. А. Тяжелая бронхиальная астма/. РМЖ, 2000, т.8, № 12 (113), с. 484.
- Чучалин Г. А. Мониторинг и лечение тяжелой бронхиальной астмы у взрослых: результаты национального многоцентрового исследования NABAT // Тег Arkh. 2005−77(3):36−42.
- Ярилин А.А. Основы иммунологии: учебник. М.: Медицина, 1999. с.250−252.
- Abdulamir AS, Hafidh RR, Abubakar F, Abbas KA. Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and"mild asthma//. BMC Immunol. 2008 Dec 16−9:73.
- Action against asthma. A strategic plan for the Department of Health, and Human Services. Washington, DC: Department of Health and Human Services- 2000.
- Adcock IM, Barnes PJ. Molecular mechanisms of corticosteroid resistance//. Chest. 2008 Aug-134(2):394−401.
- Akbari O, Faul JL, Hoyte EG, et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma//. N Engl J Med. 2006−354:1117−1129.
- Alexander A.G., Barnes N.S., Kay A.B., Corrigan С J. Clinical response to cyclosporine in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations//. Eur Respir J, 1995, 8 (4), p.574−578.
- Alexander S. Niven, Gregory Argyros. Alternate treatment in asthma//. Chest, 2003, 123, p.1254−1256
- Annesi-Maesano I. Asthma epidemiology//. Rev Prat. 2005 Jun 30- 55 (12): 1295−8
- Athlin L., Domellof L., Norberg B. Therapeutic concentrations of melphalan do not affect yeast cell phagocytosis by monocytes//. Int J Immunopharmacol, 1988, 10 (4).
- Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases//. N Engl J Med 2002- 347: 911−920.
- Bai TR, Knight DA. Structural changes in the airways in asthma: observations and consequences//. Clin Sci (Lond). 2005 Jun-108(6):463−77.i.
- Barner M., Mohrs M., Brombacher F., Kopf M. Differences between IL-4Ro--deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses//. Curr Biol, 1998, 8, p.669.
- Barnes P.J. Molecular mechanism of antiasthma therapy//. Ann Med, 1995, 27 (5), p.531−535.
- Barnes P.J., Adcock I.M. Steroid resistance in asthma//. QJM, 1995, 88 (7), p.455−468
- Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005//. Br J Pharmacol. 2006 Jun-148(3):245−54'.
- Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease//. J Clin Invest. 2008 Nov- 118(11):3546−56.
- Belvisi M.G. Regulation-of inflammatory cell function by corticosteroids//. Proc Am Thorac Soc 2004- 1(3): 207−214.
- Bernstein I.L., Bernstein, D.I., Dubb J.W., Faiferman I., Wallin В. A placebo-controlled multicenter study of auranofin in the treatment of patient with corticosteroid-dependent asthma. Auranofin Multisenter
- Drug Trial//. J. Allergy Clin. Immunol, 1996, 98 (2), 317−324.
- Blanco G., DeTomaso A.W., Koster J., Xie Z.Y., Merser R.W. The alfa-subunit of the Na, K-ATPase has catalytic activity independent of the beta-subunit //J. Biol.Chem.-1994.-v.269,m38:-pp.23 420−23 425
- Bluestone JA, Abbas AK. Opinion-regulatory lymphocytes: natural versus adaptive regulatory T cells//. Nat Rev Immunol 2003- 3: 253 257.
- Borchers M.T., Carty M.P., Leikauf G.D. Regulation of human airway mucins by acrolein and inflammatory mediators//. Am J Physiol Lung Cell Mol Physiol, 1999, vol.276, p.549−555.
- Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyperreactivity//. Am Rev Respir Dis 1980−121:389−413.
- Boushey HA. Asthma mortality//. West J Med 147:314−320 (1987)
- Bret Ratner, in: Treatment of Asthma. Edited by HAROLD A. AB-RAMSON, M.D. London: Bailliere, Tindall & Cox, Ltd. Pp. xiv+752. illustrated. Price 84s
- Brodie MD, Dixon TG. The pathology of asthma. Transactions of the Pathological Soc of London 1903-liv:17.
- Broide D.H., Negrao-Correa D., Teixeira M.M. Inhibition of eosinophil rolling and recruitment in P-selectin and intracellular adhesion molecule-deficient mice//. Blood, 1998, 91, p.2847−2856.
- Bumbacea D, Campbell D, Nguyen L et al. Parameters associated with persistent airflow obstruction in chronic severe asthma//. Eur Respir J. 2004 Jul-24(l): 122−8.
- Carroll N., Cooke C., James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics//. Eur Respir J, 1997,10 (2), p.292−300.
- Cemek M, Caksen H et al. Oxidative stress and enzymic-non-enzymic antioxidant responses in children with acute pneumonia//. Cell Bio-chem Funct. 2006 May-Jun-24(3):269−73.
- Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-b induction of transcription factor Foxp3//. J Exp Med 2003- 198: 1875−1886.
- Chobot R, Uvitsky Ш, Dundy H. The relationship of the etiologic factors in asthma in infants and children//. J Allergy 1951−22:106−110.
- Christensson C, Thoren A, Lindberg B. Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects//. Drug Saf. 2008−31(11):965~88.
- Chung K.F., Mann B.S. Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy//. Respir Res 2006 Apr 6- 7(1): 59.
- Coburn R.F. Na+, K±ATPase inhibition stimulates prostaglandin synthesis and phosphatidylinositol metabolism in smooth muscle //in: Prostagl. memb. ion transp., ed: P. Braquet et al.-1984.-p.29−34
- Cohen J, Burggraaf J, Schoemaker RC et al. Relationship between airway responsiveness to neurokinin A and methacholine in asthma//. Pulm Pharmacol Ther. 2005−18(3):171−6.
- Cohen L, E X, Tarsi J, et al. Epithelial cell proliferation contributes to airway remodeling in severe asthma//. Am J Respir Crit Care Med. 2007−176:138−145
- Cohn L., Homer R. J, MacLeod H., Mohrs M., Brombacher F., Bot-tomly K. Th2-induced airway mucus production is dependent on IL-4R, but not on eosiniphils//. J of Immunology, 1999, 162, p.6178−6183.
- Cooke RA, Vander Veer A. Human sensitization// J Immunol 1916- 1: 201−305.
- Corne JM, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and nonasthmatic individuals: A longitudinal cohort study//. 2002 Lancet 359:831−834.
- Corradi M, Pignatti P, et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation//. Eur Respir J. 2004 Dec-24(6):1011−7
- Corrigan CJ. Asthma refractory to glucocorticoids: the role of newer immunosuppressants//. Am J Respir Med. 2002-l (l):47−54.
- Cosentini R, Tarsia P, Canetta С et al. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection//. Respir Res. 2008 May 30−9:48.
- Crane J, Pearce N, Burgess C, Beasley R. Asthma and the beta agonist debate//. Thorax 1995−50(suppl 1): S5−10.
- Current trends: asthma United States, 1982−1992. MMWR, 1995, Vol.43, p.952.
- Custovic A, Simpson A. What are we learning from genetic cohort studies? // Paediatr Respir Rev. 2006−7 Suppl l: S90−2.
- Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viralinduced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells.//Nat Immunol 2004- 5: 337−343.
- Davies H., Olson L., Gibson P. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev. 2000- (2): CD000391.
- Dennis SM, Sharp SJ, Vickers MR et al. Regular inhaled salbuta-mol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework.// Lancet 2000−355:1675−9.
- Deveci F, ilhan N. Plasma malondialdehyde and serum trace element concentrations in patients with active pulmonary tuberculosis//. Biol Trace Elem Res. 2003 Oct-95(l):29−38.
- Domingo С, Moreno A, Amengual MJ, Comet R, Lujan M. Twelve years' experience with methotrexate for GINA treatment step 5 asthma patients//. Curr Med Res Opin. 2009 Feb-25(2):367−74.
- Dorscheid DR, Wojcik KR, Sun S, Marroquin B, White SR. Apop-tosis of airway epithelial cells induced by corticosteroids//. Am J Respir Crit Care Med. 2001−164:1939−1947.
- Dor’sheid D.R., Wojcik K.R., Sun s., Marraquin В., v White S.R. Apoptos of airway epithelial cells induced by corticosteroids//. Am Respir J Crit Care Med, 2001,164 (10 Ptl), p.1939−1947.
- Dykewicz M.S. Newer, and alternative non-steroid treatment for asthmatic inflammation//. Allergy Asthma Proc, 2001,22 (1), p. 11−15
- E.I. Sokolov, K.A. Zykov, et al. Inhalations of ultra-low doses of alkylating drug for the treatment of steroid-dependant asthma: antiinflammatory effect of therapy//. European Respir Journal, 2001, Vol. 21', Suppl.41, PI798
- E.I.Sokolov, K.A.Zykov et al: Therapy of asthma with melphalan: para-doxical effect of alkylating drug inhalation//. European Respir Journal, 1999, Vol. 14, Suppl.30, P2225
- Evans D.J., Cullinan P., Geddes D.M. Gold as an oral corticosteroid sparing agent in stable asthma- Cochrane database Syst Rev, 2001, 2, CD 2 985.
- Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report- 2007 Originally Printed July 1997 Revised June 2002, August 2007 NIH Publication No. 07−4051 http://www.nhlbi.nih.gov
- Fadden E.R., Warren E. L Observations on asthma mortality // Ann. Intern. Med. 1997. — V. 127, N 2. — P. 142−147.
- Fattouh R, Jordana M. TGF-beta, eosinophils and IL-13 in allergic airway remodeling: a critical appraisal with therapeutic, considerations//. Inflamm Allergy Drug Targets. 2008 Dec-7(4):224−36.
- Fehervari Z, Sakaguchi S. Development and function of CD25+CD4+ regulatory T cells. // Curr Opin Immunol 2004- 16: 203 208.
- Floreani A.A., Rennard S.I. Experimental" treatment for asth-ma.//Curr Opin Pulm Med, 1997, 3 (1), p.30−41.
- Folli C, Descalzi D, Scordamaglia F et al. New insights into airway remodelling in asthma and its possible modulation. // Curr Opin Allergy Clin Immunol. 2008 Oct-8(5):367−75.
- Ford JG, Rennick D, Donaldson DD, et al. IL-13 and IFN-y interactions in lung inflammation.// J Immunol 2001- 167: 1769−1777.
- Frew A. J, Plummeridge MJ. Alternative agents in asthma//. J Allergy Clin Immunol, 2001, 108 (1), p.3−10.
- From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2002. Available from: http://www.ginasthma.org1
- Fukaya H, Iimura A, Hoshiko К A cyclosporin, A/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma//. Eur Respir J. 2003 Aug-22(2):213−9.
- Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T. Human eotax-in is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia//. Nat Med, 1996, 2 (4), p.449−456.
- Geddes DM Methotrexate in asthma//. Clin Exp Allergy, 21 (5): 541 -3 1991' Sep
- Gelfand E.W., Dakhama A. CD8+ T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma//. J Allergy Clin Immunol 2006 Mar- 117(3): 577−82
- Gochuico BR, Miranda KM, Hessel EM Airway epithelial Fas li-gand expression: potential role in modulating bronchial inflammation//. Am J"Physiol. 1998 Mar-274(3 Pt l):L444−9.
- Godfrey DI, Kronenberg M. Going both ways: immune regulation via CDld-dependent NKT cells//. J Clin Invest. 2004−114:1379−1388
- Goleva E, Hauk PJ, Boguniewicz J, Martin RJ, Leung DY. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma//. J Allergy Clin Immunol. 2007 Nov-120(5): 1065−72.
- Gor DO, Rose NR, Greenspan NS. TH1-TH2: a Procrustean paradigm//. Nat Immunol 2003- 4: 503−505.
- Gorelik L, Prokhorova A, Mokyr MB. Bow-dose melphalan-induced shift in the production of a Th2-type cytokine to шThl -type cytokine in mice bearing a large MOPC-315 tumor//. Gancer Immunol Immunother. 1994 Aug-39(2): 117−26.
- Grcwe M, Bruijnzeel-Koomen CA, Schopf E, et al. A role for Thl and Th2 cells in the: immunopathogenesis of atopic: dermatitis//. Immunol Today 1998- 19: 359−361.
- Hagimoto N, Kuwano K, Miyazaki H, et al. Induction. of apoptosis and pulmonary fibrosis in mice in. response to ligation of Fas antigenII Am J Respir Cell Mol Biol. 1997−17:272−278.
- Hahn DL, Bukstein D, Luskin A, Zeitz H: Evidence for Chlamydia pneumoniae infection- in steroid-dependent asthma// Ann Allergy Asthma Immunol 1998, 80:45−49.
- Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype// J Allergy Clin Immunol! 2007 May- 119(5): 1043−52- quiz 1053−4.
- Hallstrand T.S., Ault K.A., Bates P., Mitchell J., Schoene R.B. Peripheral blood manifestations of Th2 lymphocyte activation in stable atopic asthmf and during exercise-induced bronchospasm// Ann Allergy Astma Immunol, 1998, 80 (5), p.424−432.
- Hamzaoui A, Rouhou SC, Grairi H, et al. NKT cells in the induced sputum of severe asthmatics// Mediators Inflarran. 2006−2006:71 214.
- Hanania NA: Targeting airway inflammation in asthma: current andifuture therapies. Chest 2008,133:989−998.
- Hansen G, Berry G, Dekruyff RH, Umetsu DT. Allergenspecific Thl cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation// J Clin Invest 1999- 103: 175−183.
- Hashimoto S, Matsumoto K, Gon Y et al Viral infection in asthma// Allergol Int. 2008 Mar-57(l):21−31.
- Hawkins GA, Weiss ST, Bleecker ER. Clinical consequences of ADRbeta2 polymorphisms// Pharmacogenomics. 2008 Mar-9(3):349−58.
- Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma// Nat Rev Immunol 2003- 3: 405112.
- Hessel EM, Van Oosterhout AJM, Van Ark I, et al. Development of airway hyperresponsiveness is dependent on ИФН-у and independent of eosinophil infiltration// Am J Respir Cell Mol Biol 1997- 16: 325 335.
- Hew M^ Bhavsar P, Torrego A et al. Relative corticosteroid insensi-tivity of peripheral blood mononuclear cells in severe asthma// Am J Respir- Crit Care Med. 2006 Jul 15- 174(2): 134−41.
- Holgate ST. Pathogenesis of asthma// Clin Exp Allergy. 2008 Jun-38(6):872−97.
- Holgate ST. The airway epithelium is central to the pathogenesis of asthma// Allergol Int. 2008 Mar-57(l):l-10.
- Holtzman-MJ, Sampath D, Castro M, Look DC, Jayaraman S. The one-two of T helper cells: does interferon-7 knock out the Th2 hypothesis for asthma? // Am J Respir Cell Mol Biol 1996- 14: 316−318.
- Honma M., Tamura G., Shirato K., Takishima T. Effect of oral’gold compound, auranofm, on non-specific bronchial hyperresponsiveness in mild asthma. // Thorax, 1994,49 (7), p.649−651.
- Hortelano S., Lopez-Collazo E., Bosca L. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages. // Br J Pharmacol, 199,126, p. l 139−1146.
- Huber HL, Koessler KK. The pathology of bronchial asthma. // Arch Intern Med 1922−30:689−760.
- Huber S, Schramm C, Lehr HA, et al. Cutting edge: TGF-b signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells//. J Immunol 2004- 173: 6526−6531.
- Inman WHW, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols// Lancet 1969−2: 279−83
- Jacobson GA, Yee КС, Ng CH. Elevated plasma glutathione peroxidase concentration in acute severe asthma: comparison with plasma glutathione peroxidase activity, selenium and malondialdehyde// Scand J Clin Lab Invest. 2007−67(4):423−30.
- Johnston SL, et al. (1995) Community study of role of viral infections in exacerbations of asthma in, 9- to 11-year-old children. // Br Med J 310:1225−1229.
- Johnston SL. Overview of virus-induced airway disease. // Proc Am Thorac Soc. 2005−2(2): 150−6.
- Joos GF. The role of neuroeffector mechanisms in the pathogenesis of asthma. // Curr Allergy Asthma Rep. 2001 Mar- 1(2): 134−43.
- K.A. Zykov, V. G. Tsyplenkova, A. L. Pukhalsky et al. New approach to treatment of steroid-dependent asthma: inhalation of very low doses of alkylat-ing drug. // European Respiratory Journal, 2000, Vol. 16, Suppl.31, P2460
- K.A.Zykov, V.I.Shevelev, et al. New method of treatment of steroid-dependant asthma with inhalations of ultra-low doses of alkylating drug: clinical results. // European Respiratory Journal, 2001, Vol. 21, Suppl.4l- P424
- Kaminuma О., Mori A., Ogawa K., Nakata A., Kikkawa H., Ikera-wa K., Okudaira H. Cloned Th cells confer eosinophilic inflammation and bronchial hyperresponsiveness// Int Arch Allergy Immunol, 1999, 118 (2−4), p. 136−139
- Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma// J' Allergy Clin Immunol 2004- 114: 1425−1433.
- Kluchova Z, Petrasova D, et al. The association between oxidative stress and obstructive lung impairment in patients with COPD// Phy-siol Res. 2007−56(l):51−6.
- Krishnakumar S, Holmes EP, Moore RM, et al. Non-adrenergic non-cholinergic excitatory innervation in the airways: role of neurokinin^ receptors// Auton Autacoid Pharmacol. 2002 Aug-22(4):215−24.
- KumarRK, Webb DC, Herbert C, Foster PS. Interferon-gamma as a possible target in chronic asthma// Inflamm Allergy Drug Targets. 2006 Dec-5(4):253−6.
- Kuwano K. Epithelial cell' apoptosis and lung remodeling// Cell Mol Immunol. 2007 Dec-4(6):419−29.
- Kuzuya T, Kobayashi T, Katayama A Evaluation of interleukin-2 mRNA in whole blood as a parameter for monitoring cyclosporine pharmacodynamics// Biol Pharm Bull. 2009 Apr-32(4):604−81
- Lai C.K., Chan C.H., Ho S.S., Hui A.C., Lai K.N. Inhaled salmete-rol and albuterol in asthmatic patients receving high-dose inhaled corticosteroids//Chest, 1995,108 (1), p.36−40.
- Lamsal M, Gautam N, et al. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis// Southeast Asian J Trop Med Public Health. 2007 Jul-38(4):695−703.
- Lanone S., et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling // J. Clin. Invest 2002 110:463-^74.
- Lattime E. С. Mastrangelo. M. J. Bagasra. O., Li, W., and Berd. D. Expression of cytokine mRNA in human melanoma tissue// Cancer Immunol. Immunother. 41:151−156. 1995.
- Laurien H. Ulfman, Dianne P.H. Joosten, Corneli W. van Aalst et al. Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions// Am J Respir Cell Mol Biol, 2003, vol.28, p.512−519.
- Lee C.G., et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating TGF-/31// J. Exp. Med. 2001 194:809−821.
- Leem JH, Kim JH, et al. Asthma attack associated with oxidative stress by exposure to ETS and PAH // J Asthma. 2005 Jul-Aug-42(6):463−7.
- Leguillette R, Laviolette M, Bergeron C, et al, Myosin, transgelin, and myosin light chain kinase: expression and function in asthma// Am J Respir Crit Care Med. 2009Feb 1−179(3): 194−204.
- Leung D.Y., Martin R.J., Szefler S.J., Sher E.R., Ying S., Kay A.B., Hamid Q. Dysregulation of interleikin-4, interleikin-5, and interferon gamma gene expression in steroid-resistant asthma// J Exp Med, 1995, 181 (1), p.33−40.
- Leung D.Y., Spahn J.D., Szefler S.J. Immunologic basis and management of steroid-resistant asthma// Allergy Asthma Proc, 1999, 20 (10), p.9−14.
- Leung D.Y., Szefler S.J. Diagnosis and management of steroid-resistant asthma// Clin Chest Med, 1997,13 (6), p.611−625.
- Leung D.Y., Szefler S J. New insights into steroid resistant asthma// Pediatr Allergy Immunol, 1998, 9 (1), p.3−12
- Leung DY, Spahn JD, Szefler SJ. Steroid-unresponsive asthma// Semin RespbCrit Care Med. 2002 Aug-23(4):387−98.
- Li GF, He YF, et al. Determination of serum superoxide dismutase, glutathione peroxidase, total antioxidative capacity, malondialdehyde in-patients with pneumonia. // Di Yi Jun Yi Da Xue Xue Bao. 2003 Sep-23(9):961−2.
- Lieberman D, Lieberman D, Printz S et al. Atypical pathogen infection in adults with acute exacerbation of bronchial' asthma// Am J* Respir Crit Care Med 2003,167:406−410:
- Liu JY, Wu Y, Zhang XS et al. Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine// Cancer ImmunoMmmunother. 2007 0ct-56(10): 1597−604.
- Longphre M., Li D., Gallup M., Drori E., Ordonez C.L. et al. Allergen-induced IL-9 directly stimulates mucin transcription respiratory epithelial cells// J Clin Invest, 1999,104 (10), p.1375−1382.
- Maggi CA, Giachetti A, Dey RD, Said SI. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins//Physiol Rev 1995−75:277−322.
- Majori M., Piccoli M.L., Bertacco S., Cuomo A., Cantini L., Pesci A. Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma// J Allergy Clin Immunol, 1997, 100 (3), p.379−382.
- Marin MG. Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysis// Chest. 1997 Jul-112(l):29−33.
- Martinez FD. The coming-of-age of the hygiene hypothesis// Respir Res. 2001−2:129−32.
- Marwick JA, Ito K, Adcock IM, Kirkham PA. Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy// Expert Opin Ther Targets. 2007 Jun-l l (6):745−55.
- Mason D, Andre P, Bensussan A et al. CD antigens 2002// Blood. 2002 May 15−99(10):3877−80.
- Matar P, Rozados VR, Gervasoni SI, Scharovsky GO Th2/Thl switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model// Cancer Immunol Immunother. 2002 Jan-50(ll):588−96.
- Matar P, Rozados VR, Gonzalez AD et al. Mechanism of antimetas-tatic immunopotentiation by low-dose cyclophosphamide// Eur J Cancer. 2000 May-36(8): 1060−6.
- Matsumano K., Taki F., Miura M, Matsuzaku M., Takagi K. Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma// Chest, 1994, 105 (3), p.681−686
- Matute-Bello G, Liles WC, Frevert CW, et al. Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits// Am J Physiol Lung Cell Mol Physiol. 2001−281:328−335.
- Matute-Bello G, Winn RK, Jonas M Fas (CD95) induces alveolar epithelial cell- apoptosis in vivo implications for acute pulmonary inflammation// Am J Pathol. 2001−158:153−161.
- Message SD, Laza-Stanca V, Mallia P et- ali Rhinovirus-induced lower respiratory illness is increased in- asthma and related to virus load and Th ½ cytokine and IL-10 production// Proc Natl Acad Sci U S A. 2008 Sep 9- 105(36): 13 562−7.
- Metzger NL, Kockler DR, Gravatt LA. Confirmed beta 16 Arg/Arg polymorphism in a patient with uncontrolled" asthma// Ann Pharma-cother. 2008 Jun-42(6):874−81.
- Meyer EH, DeBCruyff RH, Umetsu DT. T cells and NKT cells in the pathogenesis of asthma//Annu Rev Med. 2008−59:281−92- Review.
- Mills KH. Regulatory T cells: friend or foe in immunity to infection?//2004- 4: 841−855
- Mokyr MB, Brundrett RB, Colvin M, Dray S. Ability of cyclophosphamide in the absence of cross-linking activity to exert the immunomodulatory effect required for the cure of mice bearing a large MOPC-315 tumor// Cancer Res. 1986 Jul-46(7):3313−20.
- Mori A., Kaminuma O., Suco M., Inoue S. et all. Two distinct pathways of interleikin-5 synthesis in allergen specific human T-cell clones are suppressed by glucocorticoids// Blood, 1997, 89 (8), p.2891−2900.
- Morishita Y., Hirayma Y., Miyaysu K., Tabata K., Kawamura A., Ohkubo Y., Mutoh S. FK506 aerosol locally inhibits antigen-induced airway inflammation in Guinea pigs// Int Arch Allergy Immunol. 2005 Apr- 136 (4): 372−8.
- Morrow T. Implications of pharmacogenomics in the current and future treatment of asthma// J Manag Care Pharm. 2007 Jul-Aug-13(6):497−505.
- Mosmann TR, Cofftnan RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties// Annu Rev Immunol 1989, 7:145−173.
- Motoyoshi Y, Kaminoda K, Saitoh О et al. Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide// Oncol Rep. 2006 Jul-16(l):141−6.
- Murray CS Can inhaled corticosteroids influence the natural history of asthma? // Curr Opin Allergy Clin Immunol. 2008 Feb-8(l):77−81.
- Narula MK, Ahuja. GK, Whig J, Narang AP, Soni RK. Status of lipid peroxidation and plasma iron, level in bronchial asthmatic patients // Indian J Physiol Pharmacol. 2007 Jul-Sep-51(3):289−92.
- Nevzorova V.V., Konovalova T.N., Pazych S.A., Kostiushko A.V. Content of antigenic determinants Cdl6, CD25, CD95, and HLA-DR in induced sputum of patients with bronchial asthma and chronic obstructive bronchitis// Ter Arkh, 2003,75 (11), p.61−64.
- Ngoe P.L., Gold D.R., Tzianabos A.O., Weiss S.T., Celedon J.C. Cytocines, allergy, and asthma// Curr Opin Allergy Clin Immunol 2005 Apr- 5(2): 161−6
- Nierop G- Gijzel WP- Bel EH- Zwinderman AH- Dijkman JH Au-ranofm in the treatment of steroid dependent asthma: a double blind' study// Thorax, 47(5):349−54 1992
- Nomura- S., Kanazawa H., Asai K., Nomura N., Hirata K., Yoshi-kawa J. Potential mechanisms of improvement of airway hyperrespon-siveness by inhaled corticosteroid therapy in asthmatic patients,// J Asthma, 2006 mar- 43 (2): 113−7
- Omoto E, Deguchi S, Takaba S, Low-dose melphalan for treatment of high-risk mielodisplastic syndrome // Leukemia, 1996, 10 (4), p.609−614
- Ozaras R, Tahan V et al. Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist// Respirology. 2000 Sep-5(3):289−92
- Ozer H, Cowens JW, Colvin M et al. In vitro effects of 4-hydroperoxycyclophosphamide on. human immunoregulatory T subset function. I. Selective effects on lymphocyte function-in T-B cell collaboration// J Exp Med. 1982 Jan l-155(l):276−90.
- Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitatnts of asthma? symptoms//1. Epidemiology. Clin. Exp Allergy. 1992- 22:325 326.
- Paunio M, Peltola H, Virtanen M et al. Acute infections, infection pressure, and atopy// Clin Exp Allergy. 2006 May-36(5):634−9.
- Peec E.J., Richards D.F., Faith A., Lavender P., Lee Т.Н., Corrigan C.J., Hawrylowicz C.M. Interleukin-10 secreting «regulatory» T cells induced by glucocorticoids and beta2-agonists// Am J Respir Cell Mol Biol 2005 Jul- 33(1): 105−11
- Persson CG. On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter// Thorax 1985−40:881−886.
- Pham-Thi N, de Blic J, Le Bourgeois M, Dy M, Scheinmann P, Leite-de-Moraes MC. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma// J Allergy Clin Immunol. 2006−117:217−218.
- Pitchford S.C., Momi S., Giannini S., Casali L., Spina D: et al. Platelet P-selectin is required for pulmonary eosinofil and lymphocyte recruitment in a murine model of allergic inflammation// Blood, 2005, 105 (5), p.2074−2081.
- Pukhalsky A, Shmarina G, Alioshkin V, Sabelnikov A. Alkylating drugs applied in non-cytotoxic doses as a novel compounds targeting inflammatory signal pathway// Biochem Pharmacol. 2006 Nov 30−72(11): 1432−8.
- Pukhalsky A., Toptygina A., Khaudukov S. Interleukin-2 receptor /3 chain as a possible target for low doses of mafosfamide// Mediators Inflam, 1995,4, p.175−180.
- Pukhalsky A.L., Toptygina A.P. Do mafosfamide and cyclosporine A really effect of different chain of receptor to interleukin-2? // Int J Immunopharmac, 1991, vol.13, № 6, p.787.
- Pukhalsky AL, Shmarina GV. Stimulatory and protective effects of alkylating agents applied in ultra-low concentrations. // Pharmacology. 2001 -62(3): 129−32.
- Puthothu В., Krueger M., Heinze J., Forster J., Heinzmann A. Impact of EL-8 and IL-8-Receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections// Clin Mol Allergy. 2006 Feb 17- 4: 2
- Rackemann FM. A clinical classification of asthma based upon a review of six hundred and forty-eight cases// Am J Med Sci 1921 -clxii:802−811
- Randhawa I, Klaustermeyer WB. Oral corticosteroid-dependent asthma: a 30-year review// Ann Allergy Asthma Immunol. 2007 Oct-99(4):291−302
- Randolph DA, Carruthers CJL, Szabo SJ, Murphy KM, Chaplin DD. Modulation of airway inflammation by passive transfer of allergen-specific Thl and Th2 cells in a mouse model of asthma// J Immunol 1999−162:2375−83.
- Rautava S, Ruuskanen O, Ouwehand A et al The hygiene hypothesis of atopic disease—an extended version// J Pediatr Gastroenterol Nutr. 2004 Apr-38(4):378−88.
- Reed CE. The pathogenesis of asthma// Med Clin North Am 1974−58:
- Restrepo RD, Peters J. Near-fatal asthma: recognition and management// Curr Opin Pulm Med. 2008 Jan- 14(1): 13−23.
- Richeldi L, Ferrara G, Fabbri LM, Lasserson TJ, Gibson PG. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005- Issue 3.
- Romagnani S. Regulation of Th2 development in allergy// Curr Opin Immunol. 1994−6:838−46.
- Rowe J, Heaton T, Kusel M, et al. High ИФН-с production by CD8+ T cells and early sensitization among infants, at high risk of atopy// J Allergy Clin Immunol 2004- 113: 710−716:
- Rubus L., Droszcz W. The role of methotrexate in the management of severe steroid-dependent asthma// Wiad Lek. 1999- 52 (7−8): 363−6.
- Saavedra-Delgado AM, Cohen SG. Huang-Ti, the Yellow Emperor and the Nei Ching: antiquity’s earliest reference to asthma// Allergy Proc 1991−12:197−198.
- Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Metaanalysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related' deaths// Ann Intern Med. 2006 Jun 20−144(12):904−12.
- Sampath D., Castro M., Look D.C., Holtzman M.J. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma// J. Clin. Invest. 1999 103:1353−1361
- Sears MR. Epidemiology of asthma exacerbations// J Allergy Clin-Immunol. 2008 Oct-122(4):662−8
- Sears MR. Epidemiology of childhood asthma// Lancet. 1997 Oct 4−350(9083): 1015−20.
- Silva PL, Passaro CP, Cagido VR et al. Impact of lung remodelling on respiratory mechanics in a model of severe allergic inflammation// Respir Physiol Neurobiol. 2008 Feb 29−160(3):239−48.
- Simonsson BG, Jacobs FM, Nadel JA. Role of autonomic nervous system and the cough reflex in the increased responsiveness of airways in patients with obstructive airway disease// J Clin Invest 1967−46:1812−1818.
- Smith DH, Malone DC, Lawson KA et al. A national estimate of the economic costs of asthma// Am J Respir Crit Care Med. 1997- 156:787−93.
- Smith LJ, Shamsuddin M, Sporn PH, Denenberg M, Anderson J- Reduced superoxide dismutase in lung cells of patients with asthma// Free Radic Biol Med. 1997−22(7):1301−7.
- Solway J, Fredberg JJ- Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all// Am J Respir Се1ШоШоМ997- 17:144−146:
- Sousa A.R., Lane S J., Cidlowski J.A., Staynov D.Z., Lee Т.Н. Glu-cocorticod resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform// J Allergy Clin Immunol, 2000, 105 (5), p.943−950
- Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma//N Engl J Med 1992−326: 501−6
- Stanciu L.A., Roberts K., Papadopoulos N.G., Cho S.H., Holgate S.T., Coyle A.J., Johnston S.L. IL-4 increases type 2, but not type 1, cytokine production in CD8+ t cells from mild atopic asthmatics// Respir Res 2005 Jul7- 6: 67.
- Standardisation of spirometry. Series «ATS/ERS task force: standardisation of lung function testing» Ed. V. Brusasco, R. Crapo, G. Viegi Eur Respir J 2005- 26: 319−338
- Stock P, Akbari O. Recent advances in the role of NKT cells in allergic diseases and asthma// Curr Allergy Asthma Rep. 2008 Apr-8(2): 165−70.
- Stock S., Redaelli M., Luengen M., Wendland G., Civello D., Lau-terbach K.W. Asthma: prevalence and cost of illness// Eur Respir J. 2005 Jan- 25 (1): 47−53.
- Stolkind E. The history of bronchial asthma and allergy// Proc R SocMed 1933−26:1120−1126.
- Strausz J. Pathomorphology of the airways in asthma// Act Microbiol Immunol, 1998,45 (1), 15−18
- Sturm A, de Souza HS, Fiocchi C: Mucosal T cell proliferation and apoptosis in inflammatory bowel disease// Curr Drug Targets 2008, 9:381−7.
- Sykes A, Johnston, SL. Etiology of astlima exacerbations// J Allergy Clin Immunol. 2008 Oct-122(4):685−8.
- Szczepankiewicz А, — Breborowicz A, Sobkowiak P, Popiel A. No association of glucocorticoid receptor polymorphisms with asthma and response to glucocorticoids// Adv Med Sci. 2008−53(2):245−50.
- Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma// J Allergy 1968−42:203−232
- Takafuji S., Ohtoshi Т., Takizawa H. et. al: Human airway epithelial tight junctions// Microc Res Tech- 1997, suppl. 1, p.488−499.
- Taylor RC, Cullen SP,' Martin SJ: Apoptosis: controlled demolition-at the cellular level// Nat Rev Mol Cell Biol 2008, 9:231 -41.
- Teixeira-L.K., Fonseca B.P., Barboza B.A., Viola, J.P. The role of interferon-gamma on immune and allergic responses// Mem Inst Os-waldo Cruz 2005 Mar- 100 Suppl 1: 137−44.
- Temann U.A., Ray P., Flavell R.A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology// J. Clin. Invest 2002. 109:29−39.
- The BAL Cooperative Group Steering Community. Bronchoalveo-lar lavage constituents in healthy individuals, idiopatic pulmonary fibrosis and selective comparison groups. Am Rev Respir Dis 1990: 141(5 Part 2: SI69−202).
- The Global? Strategy for/ Asthma Management and" Prevention, Global Initiative for Asthma (GINA) 2007., Available from: http://www.ginasthma.org
- Trautmann A, Schmid-Grendelmeier P, Krilger К T cclls and eosinophils cooperate in the induction of bronchial epithelial cell apopto-sis in asthma//J Allergy Clin Immunol- 2002 Feb- 109(2):329−37.
- Truyen E., Coteur L., Dilissen E., Overbergh L., Dupont L.J., Ceuppens J.L., Bullens D.M. Evaluation of airway inflammation by quantitative Thl/Th2 cytokine mRNA measurement in sputum of asthma patients// Thorax 2006 Mar- 61(3): 2002−8.
- Tsukadaira A, Okubo Y, Horie S, Koyama S. Theophylline inhibits ФНО-alpha-induced CD4 expression on human eosinophils and CD4+eosinophil migration// Int Arch Allergy Immunol. 2001 Aug-125(4):335−43.
- Tutluoglu В., Gurel C.B., Osdas S.B., Muselim B. Erturan S. et al. Platelet function and fibrinolytic activity in patients with bronchial asthma// Clin Appl Thromb Hemost, 2005, 11 (1) — p.77−81.
- Umetsu DT. Revising the immunological theories of asthma and allergy// Lancet. 2005 Jan 8−14−365(9454):98−100.
- Veith I. The yellow emperor’s classic of internal’medicine// Cambridge, England: Cambridge University Press- 1966.
- Vignola AM, Chiappara G, Siena L et al. Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma// J Allergy Clin Immunol 2001−108:738−746
- Vrugt B, Wilson S., Underwood J., Bron A., de Bruyn R., Bradding P., Holgate S.T., Djukanovich R. Mucosal inflammation in severeglucocrticoid-dependent asthma// Eur Respir J, 1999, 13 (6), p. 12 451 252.
- Walter MJ, Holtzman MJ. A centennial history of research on asthma pathogenesis// Am J Respir Cell Mol Biol. 2005 Jun-32(6):483−9.
- Weiss ST, Raby BA. Asthma genetics 2003// Hum Mol Genet 2004- 13: R83-R89
- Whelan R., Kim C., Chen M., Leiter J., Grunstein M.M. Role and regulation of interleukin-1 molecules in pro-asthmatic sensitized airway smooth muscle// Eur Respir J. 2004 Oct- 24 (4): 559−67.
- White A.A., Karr D.B., Patt C.S. Role of lipoxygenase in the O2-dependent activation of soluble guanilate cyclase from rat lung //Biochem.j.-1982.-v.204,n.2.-p.383−392
- Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis// Nature Rev Immunol 2001- 1:69−75.
- Wilson J.W., Djucanovich R., Howarth P.H., Holgate S.T. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma// Am J Respir Crit Care Med, 1994, 149 (1), p.86−90.
- Wolff-Eisneer A. Das Heufieber: sein Wesen und seine Behan-dlung. Munchen: Lehmano- 1906.
- Woltman G., Ward R.J., Symon F.A. Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry// Torax, 1999, 18 (6), p.124−130.
- Worldwide variation in prevalence of symptoms of asthma- allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998 Apr 25−351(9111):1225−32.
- Wu W.C., Kao Y.H., Hu D.N. A comparative study of effects ofantiproliferative drugs on human retinal pigment epithelial cells in vitro// J Ocul Pharmacol Ther, 2002, 18 (3), p.251−261
- Xue J, Xu Y, Zhang Z: Lymphocyte apoptosis in asthmaticpatients and* its niolecular. mechanism// Zhonghua Jie He He Hu, Xi Za Zhi 1999,22(9):555−557.
- Yew W.W., Lee J., Wong P.C., Wong C.F., Chau C.H. Low-dose methotrexat in the management of Chinese patients with steroid-dependent asthma//. Drugs Exp clin Res, 1996, 22 (6), p.317−321.
- Ying S., Khan L.N., Meng Q., Barnes N.C., Kay A.B. Cyclosporin A, apoptosis of BAL T-cells and expression- of Bcl-2 in asthmatics//. Eur Respir J, 2003,22, p-207−212
- Zacarias Fluck MF, Rico MJ, Gervasoni SI et al. Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model// Cancer Immunol Immunother. 2007 Feb-56(2):237−48.
- Zhu Z., et al. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling//J. Immunol. 2002 168:2953−2962.
- Zhu Z., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production// J. Clin. Invest. 1999 103:779 788.